QQQ   437.94 (+0.27%)
AAPL   180.73 (-0.98%)
MSFT   408.94 (-0.34%)
META   484.14 (+0.02%)
GOOGL   138.18 (-4.02%)
AMZN   175.00 (+0.01%)
TSLA   199.85 (+4.10%)
NVDA   799.96 (+1.50%)
NIO   5.57 (+3.15%)
AMD   176.55 (+0.02%)
BABA   76.24 (+0.37%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.12 (+5.95%)
CGC   3.46 (+2.98%)
GE   154.55 (+0.80%)
DIS   107.95 (+0.19%)
AMC   4.56 (+2.70%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.49 (+0.63%)
QQQ   437.94 (+0.27%)
AAPL   180.73 (-0.98%)
MSFT   408.94 (-0.34%)
META   484.14 (+0.02%)
GOOGL   138.18 (-4.02%)
AMZN   175.00 (+0.01%)
TSLA   199.85 (+4.10%)
NVDA   799.96 (+1.50%)
NIO   5.57 (+3.15%)
AMD   176.55 (+0.02%)
BABA   76.24 (+0.37%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.12 (+5.95%)
CGC   3.46 (+2.98%)
GE   154.55 (+0.80%)
DIS   107.95 (+0.19%)
AMC   4.56 (+2.70%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.49 (+0.63%)
QQQ   437.94 (+0.27%)
AAPL   180.73 (-0.98%)
MSFT   408.94 (-0.34%)
META   484.14 (+0.02%)
GOOGL   138.18 (-4.02%)
AMZN   175.00 (+0.01%)
TSLA   199.85 (+4.10%)
NVDA   799.96 (+1.50%)
NIO   5.57 (+3.15%)
AMD   176.55 (+0.02%)
BABA   76.24 (+0.37%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.12 (+5.95%)
CGC   3.46 (+2.98%)
GE   154.55 (+0.80%)
DIS   107.95 (+0.19%)
AMC   4.56 (+2.70%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.49 (+0.63%)
QQQ   437.94 (+0.27%)
AAPL   180.73 (-0.98%)
MSFT   408.94 (-0.34%)
META   484.14 (+0.02%)
GOOGL   138.18 (-4.02%)
AMZN   175.00 (+0.01%)
TSLA   199.85 (+4.10%)
NVDA   799.96 (+1.50%)
NIO   5.57 (+3.15%)
AMD   176.55 (+0.02%)
BABA   76.24 (+0.37%)
T   16.59 (-1.25%)
F   12.07 (-0.58%)
MU   91.12 (+5.95%)
CGC   3.46 (+2.98%)
GE   154.55 (+0.80%)
DIS   107.95 (+0.19%)
AMC   4.56 (+2.70%)
PFE   27.12 (-2.31%)
PYPL   59.51 (+0.59%)
XOM   104.49 (+0.63%)

Olema Pharmaceuticals (OLMA) Insider Trading & Ownership

$13.39
-0.10 (-0.74%)
(As of 12:51 PM ET)

Olema Pharmaceuticals (NASDAQ:OLMA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
23.50%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$17.85 M
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$2.63 M
Get OLMA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Olema Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OLMA Insider Buying and Selling by Quarter


Olema Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/31/2024Cyrus HarmonDirectorSell25,000$12.23$305,750.00  
12/6/2023Biocapital Advisors L ParadigmMajor ShareholderBuy100,000$11.60$1,160,000.00  
12/5/2023G. Walmsley GrahamDirectorBuy131,870$14.19$1,871,235.30  
11/30/2023Cyrus HarmonDirectorSell25,000$12.57$314,250.00  
11/21/2023Cyrus HarmonDirectorSell4,192$14.86$62,293.12  
11/21/2023Naseem ZojwallaInsiderSell7,461$14.84$110,721.24  
11/21/2023Sean BohenCEOSell29,293$14.88$435,879.84  
11/8/2023David C MylesInsiderSell200$17.61$3,522.00  
11/3/2023David C MylesInsiderSell541$17.51$9,472.91  
11/2/2023Cyrus HarmonDirectorSell5,000$15.64$78,200.00  
11/1/2023David C MylesInsiderSell6,668$15.02$100,153.36  
10/31/2023Cyrus HarmonDirectorSell25,000$12.05$301,250.00  
9/29/2023Cyrus HarmonDirectorSell25,000$12.41$310,250.00  
9/19/2023David C MylesInsiderSell20,000$12.67$253,400.00  
9/12/2023Bvf Partners L P/IlDirectorBuy1,505,932$9.84$14,818,370.88  
9/5/2023Cyrus HarmonDirectorSell10,000$11.62$116,200.00  
8/31/2023Cyrus HarmonDirectorSell15,000$9.36$140,400.00  
6/8/2023Cyrus HarmonDirectorSell10,000$6.30$63,000.00  
6/5/2023Cyrus HarmonDirectorSell5,000$6.04$30,200.00  
(Data available from 1/1/2013 forward)












OLMA Insider Trading Activity - Frequently Asked Questions

Who is on Olema Pharmaceuticals's Insider Roster?

The list of insiders at Olema Pharmaceuticals includes Biocapital Advisors L Paradigm, Bvf Partners L P/Il, Cyrus Harmon, David C Myles, G. Walmsley Graham, Kinney Horn, Naseem Zojwalla, and Sean Bohen. Learn more on insiders at OLMA.

What percentage of Olema Pharmaceuticals stock is owned by insiders?

23.50% of Olema Pharmaceuticals stock is owned by insiders. Learn more on OLMA's insider holdings.

Which Olema Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased OLMA shares in the last 24 months: Biocapital Advisors L Paradigm ($1,160,000.00), Bvf Partners L P/Il ($15,624,370.88), and G. Walmsley Graham ($1,871,235.30).

How much insider buying is happening at Olema Pharmaceuticals?

Insiders have purchased a total of 1,937,802 OLMA shares in the last 24 months for a total of $18,655,606.18 bought.

Which Olema Pharmaceuticals insiders have been selling company stock?

The following insiders have sold OLMA shares in the last 24 months: Cyrus Harmon ($1,721,793.12), David C Myles ($366,548.27), Kinney Horn ($24,951.75), Naseem Zojwalla ($110,721.24), and Sean Bohen ($435,879.84).

How much insider selling is happening at Olema Pharmaceuticals?

Insiders have sold a total of 218,608 Olema Pharmaceuticals shares in the last 24 months for a total of $2,659,894.22 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:OLMA) was last updated on 2/26/2024 by MarketBeat.com Staff